All In MedTech

Device Trial Radar · NCT02110238

Non-Inferiority Study Comparing 3 Weekly Injections of SUPARTZ® vs 3 Weekly Injections of Euflexxa® for Knee OA

Multicenter, Randomized, Double-Blind, Parallel Controlled Non-Inferiority Clinical Trial Comparing 3 Weekly Intra-articular Injections of SUPARTZ® vs 3 Weekly Intra-articular Injections of Euflexxa® for Treatment of Knee OA

Last checked: Nov 19, 2026Latest source record: Mar 9, 2021 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingRandomized with 421 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

421

Actual

Start

Mar 2014

Primary completion

Nov 2014

Study completion Feb 2015

Sponsor

Lead sponsor
Bioventus LLCNot on our public-company list
Sponsor type
Industry
Collaborators
Seikagaku Corporation
First posted
Apr 10, 2014

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Randomized
Model
Parallel
Masking
Double (participant, investigator)
Primary purpose
Treatment
Who can join
All sexes, from 40 years, up to 80 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to demonstrate non-inferiority of three weekly intra-articular injections of SUPARTZ to three weekly intra-articular injections of Euflexxa for the relief of knee OA.

Conditions

  • Osteoarthritis

Interventions

  • SupartzDevice

    Treatment is 3 injections over 2 weeks; Week 0 (baseline), Week 1, and Week 2.

  • EuflexxaDevice

    Treatment is 3 injections over 2 weeks; Week 0 (baseline), Week 1, and Week 2.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. WOMAC VAS (0:None -100:Extreme) Pain Subscale Score Change From BaselineTime frame: Change from Baseline (CFB) over Weeks 3, 6, and 12

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Triangle Orthopaedic Associates

    Durham, North Carolina

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.